GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones that ...
MiniMed Group, Inc. (MiniMed), a global leader in full stack insulin delivery, today announced CE (Conformité Européenne) Mark for use of the MiniMed(TM) 780G system with the Instinct sensor, made by ...
GALWAY, Ireland, Dec. 2, 2025 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the MiniMed™ 780G system integrated ...
Medtronic (NYSE:MDT) announced on Tuesday that the U.S. FDA cleared its SmartGuard algorithm as an interoperable automated glycemic controller, allowing the integration of its MiniMed 780G insulin ...
Medtronic (MDT) announced two FDA regulatory milestones that broaden the MiniMed 780G system portfolio: clearance of the SmartGuard algorithm as an interoperable automated glycemic controller, ...
Medtronic has earned FDA approval that will allow it to broaden the scope of its MiniMed 780G system portfolio. FDA has cleared Medtronic’s SmartGuard algorithm as an interoperable automated glycemic ...
On the heels of its debut as a public company, Medtronic’s former diabetes division MiniMed has claimed a European approval to connect its mainstay insulin pump with an exclusive continuous glucose ...
NORTHRIDGE, Calif., March 10, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed), a global leader in full stack insulin delivery, today announced CE (Conformité Européenne) Mark for use of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results